Articles from Mirion

Mirion (NYSEMIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results.

Mirion (“we” or the “company”) (NYSEMIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, will host an Investor Day today, December 3, 2024, at 2:00pm ET. The event will be held at the New York Stock Exchange in New York, NY. In-person attendance requires prior registration. Interested parties may access the livestream of the event, related published materials and a replay of the event by accessing Mirion’s IR website at ir.mirion.com.

Mirion (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Goldman Sachs’ Industrials and Materials Conference in New York, NY. The presentation will begin at 10:40 AM ET on Thursday, December 5, 2024.

Mirion (NYSEMIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, today announced that it will host an Investor Day on Tuesday, December 3, 2024, beginning at 2:00 p.m. ET. The event will be held at the New York Stock Exchange and webcast live.

Mirion (NYSEMIR) announced today that it will release financial results for third quarter 2024 after market close on Tuesday, October 29, 2024. Following the news release, the company will host a conference call the next day, Wednesday, October 30, 2024, at 11:00 am ET to discuss the results.

Mirion (“we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the second quarter ended June 30, 2024.

Mirion (NYSEMIR) announced today that it will release financial results for second quarter 2024 after market close on Thursday, August 1, 2024. Following the news release, the company will host a conference call the next day, Friday, August 2, 2024, at 11:00 am ET to discuss the results.

Mirion (NYSEMIR) announced today that its management team’s presentation at Jefferies’ 2024 Global Healthcare Conference will now begin at 3:30 PM ET on Thursday, June 6, 2024.

Mirion ("we" or the "Company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it completed the redemption of its outstanding publicly traded warrants (the “Public Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), that remained outstanding at 5:00 pm New York City time on Monday, May 20, 2024 (the “Redemption Date”), for a redemption price of $0.10 per Public Warrant (the “Redemption Price”).

Mirion (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Jefferies’ 2024 Global Healthcare Conference in New York, NY. The presentation will begin at 4:00 PM ET on Thursday, June 6, 2024.

Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, previously announced on April 18, 2024, that it will redeem all of its publicly traded warrants (the “Public Warrants”) to purchase shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), that remain outstanding at 5:00 p.m. New York City time on Monday, May 20, 2024 (the “Redemption Date”), for a redemption price of $0.10 per Public Warrant (the “Redemption Price”).

Mirion (“we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the first quarter ended March 31, 2024.

Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it will redeem all of its publicly traded warrants to purchase shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), that remain outstanding at 5:00 pm New York City time on Monday, May 20, 2024 (the “Redemption Date”), for a redemption price of $0.10 per warrant (the “Redemption Price”).

Mirion (NYSEMIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024. Following the news release, the company will host a conference call the next day, Wednesday, May 1, 2024, at 9:00 am ET to discuss the results.

Mirion (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024.

Mirion (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, will participate in a SHARE Series fireside chat moderated by Wolfe Research Analyst, Nigel Coe. The event will begin at 9:00 AM ET on Monday, February 26, 2024 and will feature an online portal for investors to submit questions to ask during the event.

Mirion ("we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2023. Related materials will be available online at ir.mirion.com.

Mirion (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2024 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 1:50 PM ET on Wednesday, February 21, 2024.

Mirion (NYSEMIR) announced today that it will release financial results for the fourth quarter and full year 2023 after market close on Tuesday, February 13, 2024. Following the news release, the company will host a conference call the next day, Wednesday, February 14, 2024, at 10:00 am ET to discuss the results.

Mirion (“we” or “the company”), announced today that it will debut the new Instadose®VUE personal dosimeter, from its Dosimetry Services brand, at the 2023 Radiological Society of North America (RSNA) Meeting starting Sunday in Chicago, Illinois. Mirion Dosimetry Services joins Sun Nuclear, Capintec, and Biodex medical imaging brands in the Mirion Medical booth (#6328) at RSNA, which will feature products and services for occupational dosimetry, diagnostic imaging QA, nuclear medicine, and medical imaging tables and accessories.

Mirion ("we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the third quarter ended September 30, 2023. Related materials will be available online at ir.mirion.com. On November 1, 2023, Mirion also closed the acquisition of ec2, with a purchase price of $33 million through an all cash purchase.

Mirion (NYSEMIR), a leading provider of advanced radiation safety solutions, today announced a philanthropic partnership with RAD-AID International to help bring radiology and radiation safety education and capabilities to underserved populations around the world.

Mirion (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the Baird Global Industrial Conference in Chicago, IL. The presentation will begin at 10:40 AM ET on Tuesday, November 7, 2023.

Mirion (“we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that Michael Rossi has informed the Company of his decision to resign as Medical Group President, effective November 1, 2023, in order to assume a CEO role at another public company.

Mirion (NYSEMIR) announced today that it will release financial results for the third quarter of 2023 after market close on Wednesday, November 1, 2023. Following the news release, the company will host a conference call the next day, Thursday, November 2, 2023, at 12:00 pm ET to discuss the results.

Mirion (NYSEMIR) announced today that Chief Financial Officer, Brian Schopfer, will present at the Jefferies Industrials Conference in New York, NY. The presentation will begin at 9:00 AM ET on Wednesday, September 6, 2023.

Mirion ("we" or the "company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the second quarter ended June 30, 2023.

Mirion (NYSEMIR) announced today that it will release financial results for the second quarter of 2023 on Wednesday, August 2, 2023. Following the news release, the company will host a conference call the same day at 12:00 pm ET to discuss the results.

Mirion (NYSEMIR) announced today that it has published its inaugural Corporate Social Responsibility Report, detailing the company’s focus and commitment to advancing along its corporate citizenship journey.

Mirion (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, will present at the Jefferies Healthcare Conference in New York, NY. The presentation will begin at 11:30 AM ET on Wednesday, June 7, 2023.

Mirion (“we” or “the company”(NYSEMIR), a leading provider of advanced radiation safety solutions, today announced that it has updated the company’s corporate branding and the branding of its Industrial segment. The overall corporate entity will now be branded as simply “Mirion”, with the Industrial segment taking the name “Mirion Technologies”. The company has also completed the launch of an enhanced website representing its comprehensive portfolio of products that leverages radiation expertise in the fields of science, technology and medicine. The refreshed mirion.com enhances user experience through easy navigation, robust search and meaningful content for the entire Mirion portfolio.